Differential roles of gsk-3β during myocardial ischemia and ischemia/reperfusion

Peiyong Zhai, Sebastiano Sciarretta, Jonathan Galeotti, Massimo Volpe, Junichi Sadoshima

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Rationale: Inhibition of glycogen synthase kinase-3 (GSK-3) protects the heart during ischemia/reperfusion (I/R), yet the underlying mechanisms of cardioprotection afforded by beta isoform-specific inhibition GSK-3 remain to be elucidated. Objective: We studied the molecular mechanism mediating the effect of GSK-3β activation/inhibition upon myocardial injury during prolonged ischemia and I/R. Methods and results: Beta isoform-specific inhibition of GSK-3 by dominant negative GSK-3β in transgenic mice (Tg-DnGSK-3β) or in heterozygous GSK-3β knock-out mice (GSK-3β+/-) significantly increased, whereas activation of GSK-3β in constitutively active GSK-3β knock-in mice (βKI) significantly decreased, myocardial ischemic injury after prolonged ischemia. In contrast, inhibition of GSK-3β in Tg-DnGSK-3β or GSK-3β+/-significantly reduced, while activation of GSK-3β in βKI significantly enhanced, myocardial I/R injury. Inhibition of GSK-3β stimulated mTOR signaling and inhibited autophagy through a rapamycin-sensitive (mTOR dependent) mechanism. Rapamycin enhanced autophagy and, at the same time, abolished the effects of GSK-3β inhibition on both prolonged ischemic injury and I/R injury. Importantly, the influence of rapamycin over the effects of GSK-3β inhibition on myocardial injury was reversed by inhibition of autophagy. Conclusions: Our results suggest that beta isoform-specific inhibition of GSK-3 exacerbates ischemic injury but protects against I/R injury by modulating mTOR and autophagy.

Original languageEnglish (US)
Pages (from-to)502-511
Number of pages10
JournalCirculation research
Volume109
Issue number5
DOIs
StatePublished - Aug 19 2011

Fingerprint

Glycogen Synthase Kinase 3
Reperfusion
Myocardial Ischemia
Ischemia
Autophagy
Sirolimus
Reperfusion Injury
Wounds and Injuries
Protein Isoforms
Myocardial Reperfusion Injury

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine

Keywords

  • Beclin 1
  • GSK-3
  • apoptosis
  • autophagy
  • ischemia
  • mTOR
  • rapamycin
  • reperfusion

Cite this

Zhai, Peiyong ; Sciarretta, Sebastiano ; Galeotti, Jonathan ; Volpe, Massimo ; Sadoshima, Junichi. / Differential roles of gsk-3β during myocardial ischemia and ischemia/reperfusion. In: Circulation research. 2011 ; Vol. 109, No. 5. pp. 502-511.
@article{0190b27bf72d4a6482011ab006aee4a2,
title = "Differential roles of gsk-3β during myocardial ischemia and ischemia/reperfusion",
abstract = "Rationale: Inhibition of glycogen synthase kinase-3 (GSK-3) protects the heart during ischemia/reperfusion (I/R), yet the underlying mechanisms of cardioprotection afforded by beta isoform-specific inhibition GSK-3 remain to be elucidated. Objective: We studied the molecular mechanism mediating the effect of GSK-3β activation/inhibition upon myocardial injury during prolonged ischemia and I/R. Methods and results: Beta isoform-specific inhibition of GSK-3 by dominant negative GSK-3β in transgenic mice (Tg-DnGSK-3β) or in heterozygous GSK-3β knock-out mice (GSK-3β+/-) significantly increased, whereas activation of GSK-3β in constitutively active GSK-3β knock-in mice (βKI) significantly decreased, myocardial ischemic injury after prolonged ischemia. In contrast, inhibition of GSK-3β in Tg-DnGSK-3β or GSK-3β+/-significantly reduced, while activation of GSK-3β in βKI significantly enhanced, myocardial I/R injury. Inhibition of GSK-3β stimulated mTOR signaling and inhibited autophagy through a rapamycin-sensitive (mTOR dependent) mechanism. Rapamycin enhanced autophagy and, at the same time, abolished the effects of GSK-3β inhibition on both prolonged ischemic injury and I/R injury. Importantly, the influence of rapamycin over the effects of GSK-3β inhibition on myocardial injury was reversed by inhibition of autophagy. Conclusions: Our results suggest that beta isoform-specific inhibition of GSK-3 exacerbates ischemic injury but protects against I/R injury by modulating mTOR and autophagy.",
keywords = "Beclin 1, GSK-3, apoptosis, autophagy, ischemia, mTOR, rapamycin, reperfusion",
author = "Peiyong Zhai and Sebastiano Sciarretta and Jonathan Galeotti and Massimo Volpe and Junichi Sadoshima",
year = "2011",
month = "8",
day = "19",
doi = "10.1161/CIRCRESAHA.111.249532",
language = "English (US)",
volume = "109",
pages = "502--511",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

Differential roles of gsk-3β during myocardial ischemia and ischemia/reperfusion. / Zhai, Peiyong; Sciarretta, Sebastiano; Galeotti, Jonathan; Volpe, Massimo; Sadoshima, Junichi.

In: Circulation research, Vol. 109, No. 5, 19.08.2011, p. 502-511.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Differential roles of gsk-3β during myocardial ischemia and ischemia/reperfusion

AU - Zhai, Peiyong

AU - Sciarretta, Sebastiano

AU - Galeotti, Jonathan

AU - Volpe, Massimo

AU - Sadoshima, Junichi

PY - 2011/8/19

Y1 - 2011/8/19

N2 - Rationale: Inhibition of glycogen synthase kinase-3 (GSK-3) protects the heart during ischemia/reperfusion (I/R), yet the underlying mechanisms of cardioprotection afforded by beta isoform-specific inhibition GSK-3 remain to be elucidated. Objective: We studied the molecular mechanism mediating the effect of GSK-3β activation/inhibition upon myocardial injury during prolonged ischemia and I/R. Methods and results: Beta isoform-specific inhibition of GSK-3 by dominant negative GSK-3β in transgenic mice (Tg-DnGSK-3β) or in heterozygous GSK-3β knock-out mice (GSK-3β+/-) significantly increased, whereas activation of GSK-3β in constitutively active GSK-3β knock-in mice (βKI) significantly decreased, myocardial ischemic injury after prolonged ischemia. In contrast, inhibition of GSK-3β in Tg-DnGSK-3β or GSK-3β+/-significantly reduced, while activation of GSK-3β in βKI significantly enhanced, myocardial I/R injury. Inhibition of GSK-3β stimulated mTOR signaling and inhibited autophagy through a rapamycin-sensitive (mTOR dependent) mechanism. Rapamycin enhanced autophagy and, at the same time, abolished the effects of GSK-3β inhibition on both prolonged ischemic injury and I/R injury. Importantly, the influence of rapamycin over the effects of GSK-3β inhibition on myocardial injury was reversed by inhibition of autophagy. Conclusions: Our results suggest that beta isoform-specific inhibition of GSK-3 exacerbates ischemic injury but protects against I/R injury by modulating mTOR and autophagy.

AB - Rationale: Inhibition of glycogen synthase kinase-3 (GSK-3) protects the heart during ischemia/reperfusion (I/R), yet the underlying mechanisms of cardioprotection afforded by beta isoform-specific inhibition GSK-3 remain to be elucidated. Objective: We studied the molecular mechanism mediating the effect of GSK-3β activation/inhibition upon myocardial injury during prolonged ischemia and I/R. Methods and results: Beta isoform-specific inhibition of GSK-3 by dominant negative GSK-3β in transgenic mice (Tg-DnGSK-3β) or in heterozygous GSK-3β knock-out mice (GSK-3β+/-) significantly increased, whereas activation of GSK-3β in constitutively active GSK-3β knock-in mice (βKI) significantly decreased, myocardial ischemic injury after prolonged ischemia. In contrast, inhibition of GSK-3β in Tg-DnGSK-3β or GSK-3β+/-significantly reduced, while activation of GSK-3β in βKI significantly enhanced, myocardial I/R injury. Inhibition of GSK-3β stimulated mTOR signaling and inhibited autophagy through a rapamycin-sensitive (mTOR dependent) mechanism. Rapamycin enhanced autophagy and, at the same time, abolished the effects of GSK-3β inhibition on both prolonged ischemic injury and I/R injury. Importantly, the influence of rapamycin over the effects of GSK-3β inhibition on myocardial injury was reversed by inhibition of autophagy. Conclusions: Our results suggest that beta isoform-specific inhibition of GSK-3 exacerbates ischemic injury but protects against I/R injury by modulating mTOR and autophagy.

KW - Beclin 1

KW - GSK-3

KW - apoptosis

KW - autophagy

KW - ischemia

KW - mTOR

KW - rapamycin

KW - reperfusion

UR - http://www.scopus.com/inward/record.url?scp=80052147341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052147341&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.111.249532

DO - 10.1161/CIRCRESAHA.111.249532

M3 - Article

C2 - 21737790

AN - SCOPUS:80052147341

VL - 109

SP - 502

EP - 511

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 5

ER -